Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researchers test needle-free injector for malaria

This article was originally published in Clinica

Executive Summary

Bioject Medical Technologies has begun a US Phase I clinical trial of its needle-free injector for delivering a vaccine for malaria. Researchers at the US Army Medical Research Institute of Infectious Diseases are testing the Biojector 2000 jet injector as a means of delivering a DNA-based vaccine made by US gene-based pharmaceutical company Vical. There are currently no available vaccines for malaria. Pharmaceutical company Merck recently pulled out of a deal with Bioject (see Clinica No 849, p 13).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel